Piperidinyl and piperazinyl modulators of &ggr;-Secretase

Details for Australian Patent Application No. 2008312612 (hide)

Owner Janssen Pharmaceutica, N.V.

Inventors Ho, Chih Yung

Agent Shelston IP

Pub. Number AU-A-2008312612

PCT Pub. Number WO2009/052126

Priority 60/981,189 19.10.07 US

Filing date 15 October 2008

Wipo publication date 23 April 2009

International Classifications

C07D 211/18 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

A61K 31/445 (2006.01) - Non-condensed piperidines, e.g. piperocaine

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

C07D 211/38 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 241/04 (2006.01) Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings

C07D 295/155 (2006.01) Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

C07D 401/06 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/10 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 417/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

6 May 2010 PCT application entered the National Phase

  PCT publication WO2009/052126 Priority application(s): WO2009/052126

27 May 2010 Corrigenda

  PCT applications that have entered the National Phase - Name Index Under the name Janssen Pharmaceutica, N.V., Application No. 2008312612, under INID (54) correct the title to read Piperidinyl and piperazinyl modulators of gamma-secretase

22 July 2010 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 18 Jun 2010

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008312614-Degenerate oligonucleotides and their uses

2008312611-Human anti-amyloid antibodies, compositions, methods and uses